BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 14645915)

  • 1. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague.
    Veits J; Lüschow D; Kindermann K; Werner O; Teifke JP; Mettenleiter TC; Fuchs W
    J Gen Virol; 2003 Dec; 84(Pt 12):3343-3352. PubMed ID: 14645915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene.
    Lüschow D; Werner O; Mettenleiter TC; Fuchs W
    Vaccine; 2001 Jul; 19(30):4249-59. PubMed ID: 11457552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
    J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
    Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers.
    Palomino-Tapia VA; Zavala G; Cheng S; García M
    Avian Pathol; 2019 Jun; 48(3):209-220. PubMed ID: 30640536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X; Shao Y; Han Z; Sun J; Liu S
    Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
    Perez-Contreras A; Barboza-Solis C; Najimudeen SM; Checkley S; Meer FV; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Ojkic D; Abdul-Careem MF
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of A20 infectious laryngotracheitis vaccine take in meat chickens using swab and dust samples following mass vaccination in drinking water.
    Assen AM; Stillman M; Alfirevich S; Gerber PF; Groves PJ; Walkden-Brown SW
    Vet Microbiol; 2020 Dec; 251():108903. PubMed ID: 33176212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection Efficacy of the Infectious Laryngotracheitis (ILT) Serva CEO Vaccine Strain in Broiler Chickens Under Different Vaccination Coverage Conditions.
    Assen AM; Gerber PF; Walkden-Brown SW
    Avian Dis; 2023 Jun; 67(2):160-169. PubMed ID: 37556295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens.
    Helferich D; Veits J; Teifke JP; Mettenleiter TC; Fuchs W
    J Gen Virol; 2007 Mar; 88(Pt 3):732-742. PubMed ID: 17325345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation and protection efficacy of ORF C gene-deleted recombinant of infectious laryngotracheitis virus.
    Garcia M; Spatz SJ; Cheng Y; Riblet SM; Volkening JD; Schneiders GH
    J Gen Virol; 2016 Sep; 97(9):2352-2362. PubMed ID: 27283114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Quinteros JA; Diaz-Méndez A; Thilakarathne D; Fakhri O; Vaz PK; Devlin JM
    Vaccine; 2018 Sep; 36(38):5709-5716. PubMed ID: 30104116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin.
    Boyle DB; Selleck P; Heine HG
    Aust Vet J; 2000 Jan; 78(1):44-8. PubMed ID: 10736685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced infection of avian influenza virus H9N2 with infectious laryngeotracheitis vaccination in chickens.
    Arafat N; Eladl AH; Marghani BH; Saif MA; El-Shafei RA
    Vet Microbiol; 2018 Jun; 219():8-16. PubMed ID: 29778208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.